Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Helen Leis

Partner, Health & Life Sciences, Oliver Wyman

Returning to work, school, and daily life in a recovering economy means co-existing with COVID-19.

Partner, Health & Life Sciences, Oliver Wyman
Partner and Vice Chairman, Financial Services, Americas, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

Q&A with a Pandemic Response Expert

How COVID-19 testing, contact tracing, and targeted quarantine may revive consumer and employee confidence.

Partner, Health & Life Sciences, Oliver Wyman

As parts of the nation begin to re-open, new considerations are unfolding that leaders struggle to manage.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Key takeaways for navigating COVID-19 as lockdowns are lifted and economies are reopened.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Businesses must prepare now for the long haul of COVID-19 suppression if they are to survive in a changed economy.

Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Partner and Co-Lead of Digital Transformation, EMEA, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Evaluating healthcare workforce supply and demand.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

When COVID-19 is Found in Your Area, What’s Your Game Plan?

Important considerations for all healthcare providers navigating the effects of coronavirus.

Partner and Chief Medical Officer, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Men hold most (87 percent) of C-suite roles at healthcare’s top ranks. But why?

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

What the future may hold for four big company names looking to become big names in healthcare.

Partner, Health & Life Sciences, Oliver Wyman

Shifting demand will change the nature of work in healthcare.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Senior Workforce Strategy Consultant, Mercer

Insights in your inbox

Subscribe